HIV-Positive Patients With Cancer Need to Be Included in Clinical Drug Trials

Charles Kohler
Voice

Description

Viral infections such as HIV may increase a person’s risk for developing several malignancies. However, most investigational drug studies exclude HIV-positive patients with cancer and optimal treatment regimens remain unknown.

View Article @ voice.ons.org

ONS Voice Articles

ONS's member magazine articles.

View All Voice Articles

Related Topics